The Australia & New Zealand healthcare contract research organizations (CROs) market was valued at approximately USD 1.45 billion in 2025 and is projected to reach USD 3.35 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.02% from 2025 to 2033. Market growth is supported by strong regulatory and ethical frameworks, government incentives, investment in research and development (R&D), advanced infrastructure, and a diverse patient population.